NO304518B1 - Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem - Google Patents

Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem

Info

Publication number
NO304518B1
NO304518B1 NO940908A NO940908A NO304518B1 NO 304518 B1 NO304518 B1 NO 304518B1 NO 940908 A NO940908 A NO 940908A NO 940908 A NO940908 A NO 940908A NO 304518 B1 NO304518 B1 NO 304518B1
Authority
NO
Norway
Prior art keywords
benzimidazoles
medicament
manufacture
pharmaceutical preparations
hydrogen
Prior art date
Application number
NO940908A
Other languages
English (en)
Norwegian (no)
Other versions
NO940908D0 (no
NO940908L (no
Inventor
S Ren-Peter Olesen
Leif Helth Jensen
Peter Moldt
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of NO940908D0 publication Critical patent/NO940908D0/no
Publication of NO940908L publication Critical patent/NO940908L/no
Publication of NO304518B1 publication Critical patent/NO304518B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO940908A 1993-03-15 1994-03-14 Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem NO304518B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93288A DK28893D0 (da) 1993-03-15 1993-03-15 Benzimidazole derivater, deres fremstilling og anvendelse

Publications (3)

Publication Number Publication Date
NO940908D0 NO940908D0 (no) 1994-03-14
NO940908L NO940908L (no) 1994-09-16
NO304518B1 true NO304518B1 (no) 1999-01-04

Family

ID=8091872

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940908A NO304518B1 (no) 1993-03-15 1994-03-14 Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem

Country Status (14)

Country Link
US (1) US5475015A (de)
EP (1) EP0617023B1 (de)
JP (1) JP3748901B2 (de)
KR (1) KR100300800B1 (de)
AT (1) ATE172453T1 (de)
AU (1) AU679023B2 (de)
CA (1) CA2118997C (de)
DE (1) DE69414017T2 (de)
DK (2) DK28893D0 (de)
ES (1) ES2123741T3 (de)
FI (1) FI941214L (de)
NO (1) NO304518B1 (de)
NZ (1) NZ260049A (de)
ZA (1) ZA941816B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
ATE373642T1 (de) * 1999-08-03 2007-10-15 Abbott Lab Kalium kanalaktivatoren
DE10209520A1 (de) * 2002-03-04 2003-09-25 4Sc Ag Neue Modulatoren von Kaliumkanälen
WO2004002962A1 (en) * 2002-06-26 2004-01-08 Poseidon Pharmaceuticals A/S Novel benzimidazol-2-one derivatives and their use
WO2005035498A1 (ja) * 2003-10-08 2005-04-21 Dainippon Sumitomo Pharma Co., Ltd. 含窒素二環性化合物の摂食調節剤としての用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments
US5200422A (en) * 1990-09-24 1993-04-06 Neurosearch A/S Benzimidazole derivatives, their preparation and use

Also Published As

Publication number Publication date
US5475015A (en) 1995-12-12
NO940908D0 (no) 1994-03-14
NZ260049A (en) 1996-03-26
DK0617023T3 (da) 1999-06-28
ATE172453T1 (de) 1998-11-15
CA2118997A1 (en) 1994-09-16
EP0617023B1 (de) 1998-10-21
FI941214A7 (fi) 1994-09-16
FI941214L (fi) 1994-09-16
DE69414017D1 (de) 1998-11-26
ES2123741T3 (es) 1999-01-16
ZA941816B (en) 1995-10-13
DK28893D0 (da) 1993-03-15
NO940908L (no) 1994-09-16
AU5649294A (en) 1994-09-22
JP3748901B2 (ja) 2006-02-22
DE69414017T2 (de) 1999-04-08
KR940021534A (ko) 1994-10-19
FI941214A0 (fi) 1994-03-15
EP0617023A1 (de) 1994-09-28
CA2118997C (en) 2002-05-28
JPH06321910A (ja) 1994-11-22
KR100300800B1 (ko) 2001-11-22
AU679023B2 (en) 1997-06-19

Similar Documents

Publication Publication Date Title
MX9203543A (es) Medicamento.
NL300382I1 (nl) Treatment of pompe's disease
AU549481B2 (en) Hair growing agent
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
BR9714677A (pt) "enantiÈmeros 3-piridila e seu uso como analgésicos"
BR9808938A (pt) Composto, composição farmacêutica, uso de um composto, processos para o tratamento de um distúrbio ou doença de um corpo de animal vivo e para a preparação de um composto, e, uso de bloqueadores de canal de cloreto
DK0975595T3 (da) Kokainanaloger
PT920865E (pt) Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos
DE69322251D1 (de) Medizinische zusammensetzung
AU8276791A (en) Benzimidazole derivatives, their preparation and use
FR2713637B1 (fr) Nouveaux composés bi-aromatiques dérivés d'amide, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
NO172043C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
FI941214A0 (fi) Bentsimidatsolin johdannaisia, niiden valmistus ja käyttö
BR0213633A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ou ativação aberrante de leucócitos
IT1223395B (it) Composti ad attivita' cardiovascolare
DE3877499D1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
EP0987022A4 (de) Vorbeugende und heilende arzneimittel für ulzerative kolitis und/oder morbus crohn
NO20082299L (no) Anvendelse av et pleuromutilinderivat innen veterinaermedisin samt fremgangsmate for fremstilling av et medikament omfattende forbindelsen